'Kundapur accident that claimed lives of 8 students could have been avoided'

French Nobel prize winning scientist Luc Montagnier has sparked a fresh controversy by claiming that the SARS-CoV-2 virus came from a lab, and is the result of an attempt to manufacture a vaccine against the AIDS virus.

In an interview given to French CNews channel and during a podcast by Pourquoi Docteur, professor Montagnier who co-discovered HIV (Human Immunodeficiency Virus) claimed the presence of elements of HIV in the genome of the coronavirus and even elements of the "germ of malaria" are highly suspect, according to a report in Asia Times.

"The Wuhan city laboratory has specialized in these coronaviruses since the early 2000s. They have expertise in this area," he was quoted as saying.

The theory that Covid-19 virus originated in the lab is making rounds for quite some time.

US President Donald Trump last week acknowledged Fox News report that the novel coronavirus may have been accidentally leaked by an intern working at the Wuhan Institute of Virology in China.

The Fox News, in an exclusive report, based on unnamed sources has claimed that though the virus is a naturally occurring strain among bats and not a bioweapon, but it was being studied in Wuhan laboratory.

The initial transmission of the virus was bat-to-human, the news channel said, adding that the "patient zero" worked at the laboratory. The lab employee was accidentally infected before spreading the disease among the common people outside the lab in Wuhan city.

Professor Montagnier was awarded the 2008 Nobel Prize in Medicine for the identification of AIDS virus, with his colleague professor Franeoise Barre-Sinoussi.

His fresh claim on coronavirus, however, received criticism from scientists, including his colleagues.

"Just in case you don't know. Dr Montagnier has been rolling downhill incredibly fast in the last few years. From baselessly defending homeopathy to becoming an antivaxxer. Whatever he says, just don't believe him," tweeted Juan Carlos Gabaldon.

As per a recent Washington Post, two years ago, the US embassy officials in China raised concerns about the insufficient biosafety at the Chinese government's Wuhan Institute of Virology where deadly viruses and infectious diseases are studied.

Though the institute, located quite close to the Wuhan wet market, is China's first biosafety level IV lab, the US state department had warned in 2018 about "serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory".

Mangaluru, Jun 6: As buses in Karnataka are operating following precautionary measures issued by the government to combat COVID-19, a few bus conductors were seen working wearing protective gears resembling personal protective equipment (PPE) on Saturday.

The Karnataka government had allowed resumption of bus services in the state during the fourth phase of COVID-19 lockdown, which ended on May 31.

The private buses were also equipped with hand sanitiser for the passengers. All the passengers were seen wearing face masks and maintaining distance from each other.

One of the bus conductors, en route State bank to Shaktinagar in Mangaluru was, was seen fully covered with protective suit.  

Sudarshan, a private bus conductor, also covered his face with a face shield. "PPE kit is for our protection and it is a must to keep ourselves and our passengers safe from COVID-19. All necessary equipment, including sanitisers and masks to fight COVID-19 have been provided by our bus owner to us," Sudarshan said.

Bengaluru, May 30: People travelling to Bengaluru by flight or train must pay to get their Covid-19 tests done at designated private labs.

This is being done to improve the participation of private labs that have been approved by the Indian Council of Medical Research to do testing. Many of these labs are running at sub-optimal levels.

The new rule will also help the special categories of passengers and their attendants to leave early for home quarantine after giving the sample once the swab collection centres are established at airports and railway stations. The nodal officers at these places will coordinate in establishing the swab collection centres.

Each test will cost Rs 650 per sample. XCyton Diagnostics will cater to air passengers. Rail passengers will be tested at Neuberg Anand Reference Laboratory, Cancyte Technologies Pvt Ltd, Aster Labs, Narayana Hrudayalaya, Vydehi Hospital and Syngene International Ltd.